Natalie Hyland
About Natalie Hyland
Natalie Hyland is an Early Clinical Lead with extensive experience in clinical research and trial coordination. She has worked in various roles across multiple organizations, including Hammersmith Medicines Research Ltd, Amgen, and Cancer Research UK.
Current Role at Adaptimmune
Natalie Hyland serves as an Early Clinical Lead at Adaptimmune, a position she has held since 2021. In this role, she is responsible for overseeing early clinical development projects, ensuring that they align with the company's strategic objectives. Her experience in clinical trials and project management contributes to the advancement of innovative therapies within the organization.
Previous Experience in Clinical Trials
Prior to her current role, Natalie Hyland accumulated extensive experience in clinical trial coordination and management. She worked as a Clinical Trial Coordinator at Hammersmith Medicines Research Ltd in London from 2002 to 2003 and at Holdsworth House Medical Practice in Sydney from 2004 to 2005. Additionally, she held positions as a Clinical Research Associate at Kendle International Inc and as a Clinical Study Manager at Amgen and Cancer Research UK.
Clinical Scientist Background
From 2017 to 2021, Natalie Hyland worked as a Clinical Scientist in Oxford, England. In this capacity, she contributed to the design and implementation of clinical studies, focusing on the evaluation of new therapies. Her role involved collaboration with cross-functional teams to ensure the successful execution of clinical research projects.
Educational Background
Natalie Hyland studied at the University of Leeds from 1998 to 2001, where she completed her degree. This educational foundation provided her with the necessary knowledge and skills to pursue a career in clinical research and development.
Career Progression in Clinical Research
Throughout her career, Natalie Hyland has held various positions in clinical research, including Clinical Project Leader at Bio Products Laboratory Limited from 2013 to 2017 and Operations and Science Lead at GSK from 2011 to 2013. Her diverse roles have equipped her with a comprehensive understanding of the clinical trial process and project management.